Promising Ebola Drug ZMapp: The Real Lessons of an Inconclusive Study - Live Science

Live Science
Promising Ebola Drug ZMapp: The Real Lessons of an Inconclusive Study
Live Science
In the midst of the 2014 Ebola outbreak, a drug called ZMapp was one of the most promising treatments for the disease. But now researchers have published a study of the medication in people, and the results are somewhat anticlimactic. Rather than ...
Study finds Ebola treatment ZMapp holds promise, although results not definitiveNational Institutes of Health (press release)
So much for that mira